Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Earnings
News

Aprea Therapeutics Q4 EPS $(0.36) Up From $(0.73) YoY

Aprea Therapeutics (NASDAQ:APRE) reported quarterly losses of $(0.36) per share. This is a 50.68 percent increase over losses of $(0.73) per share from the same period last year.

byBenzinga Newsdesk

March 15, 2022

1 minute read

Aprea Therapeutics (NASDAQ:APRE) reported quarterly losses of $(0.36) per share. This is a 50.68 percent increase over losses of $(0.73) per share from the same period last year.